Free for academic non-profit institutions. Other users need a Commercial license

Aliases for PRKACA Gene

Aliases for PRKACA Gene

  • Protein Kinase CAMP-Activated Catalytic Subunit Alpha 2 3 5
  • Protein Kinase, CAMP-Dependent, Alpha Catalytic Subunit 2 3
  • Protein Kinase, CAMP-Dependent, Catalytic, Alpha 2 3
  • EC 2.7.11.11 4 61
  • PKA C-Alpha 3 4
  • PKACA 3 4
  • CAMP-Dependent Protein Kinase Catalytic Subunit Alpha 3
  • Protein Kinase A Catalytic Subunit 3
  • EC 2.7.11 61
  • PPNAD4 3

External Ids for PRKACA Gene

Previous GeneCards Identifiers for PRKACA Gene

  • GC19M014557
  • GC19M014047
  • GC19M014063
  • GC19M014202
  • GC19M013774

Summaries for PRKACA Gene

Entrez Gene Summary for PRKACA Gene

  • This gene encodes one of the catalytic subunits of protein kinase A, which exists as a tetrameric holoenzyme with two regulatory subunits and two catalytic subunits, in its inactive form. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Four different regulatory subunits and three catalytic subunits have been identified in humans. cAMP-dependent phosphorylation of proteins by protein kinase A is important to many cellular processes, including differentiation, proliferation, and apoptosis. Constitutive activation of this gene caused either by somatic mutations, or genomic duplications of regions that include this gene, have been associated with hyperplasias and adenomas of the adrenal cortex and are linked to corticotropin-independent Cushing's syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. Tissue-specific isoforms that differ at the N-terminus have been described, and these isoforms may differ in the post-translational modifications that occur at the N-terminus of some isoforms. [provided by RefSeq, Jan 2015]

GeneCards Summary for PRKACA Gene

PRKACA (Protein Kinase CAMP-Activated Catalytic Subunit Alpha) is a Protein Coding gene. Diseases associated with PRKACA include Pigmented Nodular Adrenocortical Disease, Primary, 4 and Hepatocellular Fibrolamellar Carcinoma. Among its related pathways are RET signaling and DAG and IP3 signaling. GO annotations related to this gene include transferase activity, transferring phosphorus-containing groups and protein tyrosine kinase activity. An important paralog of this gene is PRKACB.

UniProtKB/Swiss-Prot for PRKACA Gene

  • Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis. Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP. RORA is activated by phosphorylation. Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts. Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP. Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated. RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activation by phosphorylation stimulates proteasome. Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding. Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation. May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT). Phosphorylates APOBEC3G and AICDA. Isoform 2 phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation.

Tocris Summary for PRKACA Gene

  • Protein kinase A (PKA, aka cAMP-dependent protein kinase) is involved in the regulation of lipid and glucose metabolism and is a component of the signal transduction mechanism of certain GPCRs. PKA is composed of two regulatory subunits and two catalytic subunits.

Gene Wiki entry for PRKACA Gene

No data available for PharmGKB "VIP" Summary , fRNAdb sequence ontologies and piRNA Summary for PRKACA Gene

Genomics for PRKACA Gene

Regulatory Elements for PRKACA Gene

Enhancers for PRKACA Gene
GeneHancer Identifier Enhancer Score Enhancer Sources Gene-Enhancer Score TSS distance (kb) Number of Genes Away Size (kb) Transcription Factor Binding Sites within enhancer Gene Targets for Enhancer
GH19F014135 1.2 ENCODE 27.8 -20.0 -20001 5.5 HDGF PKNOX1 CREB3L1 ARID4B SIN3A DMAP1 ZNF2 YY1 ZNF143 ZNF207 PRKACA CCDC130 MRI1 SYDE1 SNRPGP15 ZNF333 DCAF15 PALM3 LOC100507373 PIR43598
GH19F014080 1.7 FANTOM5 Ensembl ENCODE 18.1 +36.6 36584 3.0 HDGF PKNOX1 ARNT CREB3L1 WRNIP1 ARID4B SIN3A DMAP1 YY1 ZNF207 PRKACA CCDC130 PALM3 ZNF333 ITGB1P1 MRI1 TRMT1 ADGRE5 ZSWIM4 ADGRL1
GH19F014111 1.5 FANTOM5 ENCODE 17.4 +2.0 1950 9.3 HDGF PKNOX1 ARNT ZFP64 ARID4B SIN3A ZNF2 YY1 ZNF143 FOS CCDC130 MRI1 TRMT1 ZNF333 RFX1 DCAF15 PRKACA MIR24-2 MIR639 ADGRE5
GH19F014085 0.9 Ensembl 26.3 +32.5 32465 1.1 HDGF ARNT ARID4B DMAP1 YBX1 NFXL1 ZNF2 ZNF48 RAD21 RARA PRKACA LOC100507373 C19orf67 GC19M014079
GH19F014106 1.2 Ensembl ENCODE 16 +10.4 10379 1.6 HDGF KLF17 SIN3A ZEB1 ZNF366 ZNF391 KLF13 SMARCA5 SP3 ZBTB2 PRKACA NANOS3 LOC100507373 GC19M014096 LOC105372286
- Elite enhancer and/or Elite enhancer-gene association Download GeneHancer data dump

Enhancers around PRKACA on UCSC Golden Path with GeneCards custom track

Promoters for PRKACA Gene
Ensembl Regulatory Elements (ENSRs) TSS Distance (bp) Size (bp) Binding Sites for Transcription Factors within promoters
ENSR00001418041 84 2801 HDGF PKNOX1 ZFP64 ARID4B SIN3A ZNF2 YY1 ZNF143 FOS CEBPZ

Genomic Location for PRKACA Gene

Chromosome:
19
Start:
14,091,688 bp from pter
End:
14,118,084 bp from pter
Size:
26,397 bases
Orientation:
Minus strand

Genomic View for PRKACA Gene

Genes around PRKACA on UCSC Golden Path with GeneCards custom track

Cytogenetic band:
PRKACA Gene in genomic location: bands according to Ensembl, locations according to GeneLoc (and/or Entrez Gene and/or Ensembl if different)
Genomic Location for PRKACA Gene
GeneLoc Logo Genomic Neighborhood Exon StructureGene Density

RefSeq DNA sequence for PRKACA Gene

Proteins for PRKACA Gene

  • Protein details for PRKACA Gene (UniProtKB/Swiss-Prot)

    Protein Symbol:
    P17612-KAPCA_HUMAN
    Recommended name:
    cAMP-dependent protein kinase catalytic subunit alpha
    Protein Accession:
    P17612
    Secondary Accessions:
    • Q32P54
    • Q9H2Y0
    • Q9NRB4
    • Q9NRH9

    Protein attributes for PRKACA Gene

    Size:
    351 amino acids
    Molecular mass:
    40590 Da
    Quaternary structure:
    • A number of inactive tetrameric holoenzymes are produced by the combination of homo- or heterodimers of the different regulatory subunits associated with two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. The cAMP-dependent protein kinase catalytic subunit binds PJA2. Both isoforms 1 and 2 forms activate cAMP-sensitive PKAI and PKAII holoenzymes by interacting with regulatory subunit (R) of PKA, PRKAR1A/PKR1 and PRKAR2A/PKR2, respectively. Interacts with NFKB1, NFKB2 and NFKBIA in platelets; these interactions are disrupted by thrombin and collagen. Binds to ABL1 in spermatozoa and with CDC25B in oocytes. Interacts with APOBEC3G and AICDA. Interacts with RAB13; downstream effector of RAB13 involved in tight junction assembly.

    Three dimensional structures from OCA and Proteopedia for PRKACA Gene

    Alternative splice isoforms for PRKACA Gene

    UniProtKB/Swiss-Prot:

neXtProt entry for PRKACA Gene

Selected DME Specific Peptides for PRKACA Gene

P17612:
  • GDTSNFDDYEEE
  • EKCGKEF
  • GRFSEPHA
  • TLGTGSFGRV
  • EHTLNEKRILQA
  • GTPEYLAPE
  • HKWFATTDWIAIYQRKVEAPFIPKF
  • RDLKPENLLIDQQGY
  • ESVKEFLAKAKE
  • LGVLIYEM
  • YLAPEII
  • YLHSLDLI
  • SDLKDLLRNLLQVDLTKR
  • VDWWALGVL
  • GVNDIKN
  • LKPENLL
  • RDLKPEN
  • TDFGFAK
  • ADQPIQIYEKIVSG
  • DIKNHKWF

Post-translational modifications for PRKACA Gene

  • Asn-3 is partially deaminated to Asp giving rise to 2 major isoelectric variants, called CB and CA respectively.
  • Autophosphorylated. Phosphorylation is enhanced by vitamin K(2). Phosphorylated on threonine and serine residues. Phosphorylation on Thr-198 is required for full activity.
  • Phosphorylated at Tyr-331 by activated receptor tyrosine kinases EGFR and PDGFR; this increases catalytic efficienncy.
  • Modification sites at PhosphoSitePlus
  • Modification sites at neXtProt

Domains & Families for PRKACA Gene

Graphical View of Domain Structure for InterPro Entry

P17612

UniProtKB/Swiss-Prot:

KAPCA_HUMAN :
  • Contains 1 AGC-kinase C-terminal domain.
  • Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. cAMP subfamily.
Domain:
  • Contains 1 AGC-kinase C-terminal domain.
  • Contains 1 protein kinase domain.
Family:
  • Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. cAMP subfamily.
genes like me logo Genes that share domains with PRKACA: view

Function for PRKACA Gene

Molecular function for PRKACA Gene

GENATLAS Biochemistry:
protein kinase,cAMP-dependent,catalytic,alpha subunit
UniProtKB/Swiss-Prot CatalyticActivity:
ATP + a protein = ADP + a phosphoprotein.
UniProtKB/Swiss-Prot EnzymeRegulation:
Allosterically activated by various compounds, including ATP. Activated by cAMP; the nucleotide acts as a dynamic and allosteric activator by coupling the two lobes of apo PKA, enhancing the enzyme dynamics synchronously and priming it for catalysis. Inhibited by H89 (N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide), spiroindoline, azole-based inhibitors, (3s)-amino-aminomethylbenzamide analogs, ARC-1032 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-carbamoylbutyl]hexanamide), ARC-1034 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]hexanamide), ARC-582, ARC-902 (Adc-6-aminohexanoic acid-(D-Arg)(6)-NH(2)), ARC-1012 ((2R)-6-amino-2-(6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}hexanamido)-N-(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)hexanamide) and ARC-1039 (6-{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]formamido}-N-[(1R)-1-[(5-{[(1R)-4-carbamimidamido-1-{[(1R)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}butyl]carbamoyl}pentyl)carbamoyl]ethyl]he xanamide).
UniProtKB/Swiss-Prot Function:
Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis. Phosphorylates CDC25B, ABL1, NFKB1, CLDN3, PSMC5/RPT6, PJA2, RYR2, RORA and VASP. RORA is activated by phosphorylation. Required for glucose-mediated adipogenic differentiation increase and osteogenic differentiation inhibition from osteoblasts. Involved in the regulation of platelets in response to thrombin and collagen; maintains circulating platelets in a resting state by phosphorylating proteins in numerous platelet inhibitory pathways when in complex with NF-kappa-B (NFKB1 and NFKB2) and I-kappa-B-alpha (NFKBIA), but thrombin and collagen disrupt these complexes and free active PRKACA stimulates platelets and leads to platelet aggregation by phosphorylating VASP. Prevents the antiproliferative and anti-invasive effects of alpha-difluoromethylornithine in breast cancer cells when activated. RYR2 channel activity is potentiated by phosphorylation in presence of luminal Ca(2+), leading to reduced amplitude and increased frequency of store overload-induced Ca(2+) release (SOICR) characterized by an increased rate of Ca(2+) release and propagation velocity of spontaneous Ca(2+) waves, despite reduced wave amplitude and resting cytosolic Ca(2+). PSMC5/RPT6 activation by phosphorylation stimulates proteasome. Negatively regulates tight junctions (TJs) in ovarian cancer cells via CLDN3 phosphorylation. NFKB1 phosphorylation promotes NF-kappa-B p50-p50 DNA binding. Involved in embryonic development by down-regulating the Hedgehog (Hh) signaling pathway that determines embryo pattern formation and morphogenesis. Prevents meiosis resumption in prophase-arrested oocytes via CDC25B inactivation by phosphorylation. May also regulate rapid eye movement (REM) sleep in the pedunculopontine tegmental (PPT). Phosphorylates APOBEC3G and AICDA. Isoform 2 phosphorylates and activates ABL1 in sperm flagellum to promote spermatozoa capacitation.

Enzyme Numbers (IUBMB) for PRKACA Gene

Gene Ontology (GO) - Molecular Function for PRKACA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000166 nucleotide binding IEA --
GO:0004672 protein kinase activity IEA --
GO:0004674 protein serine/threonine kinase activity IEA,TAS --
GO:0004691 cAMP-dependent protein kinase activity NAS,TAS --
GO:0004712 protein serine/threonine/tyrosine kinase activity IDA 22797923
genes like me logo Genes that share ontologies with PRKACA: view
genes like me logo Genes that share phenotypes with PRKACA: view

Human Phenotype Ontology for PRKACA Gene

HPO Id HPO Name Alternative Ids Definition Synonyms

Animal Models for PRKACA Gene

MGI Knock Outs for PRKACA:

Animal Model Products

Inhibitory RNA Products

Clone Products

Flow Cytometry Products

No data available for Transcription Factor Targets and HOMER Transcription for PRKACA Gene

Localization for PRKACA Gene

Subcellular locations from UniProtKB/Swiss-Prot for PRKACA Gene

Cytoplasm. Cell membrane. Nucleus. Mitochondrion. Membrane; Lipid-anchor. Note=Translocates into the nucleus (monomeric catalytic subunit). The inactive holoenzyme is found in the cytoplasm. Distributed throughout the cytoplasm in meiotically incompetent oocytes. Associated to mitochondrion as meiotic competence is acquired. Aggregates around the germinal vesicles (GV) at the immature GV stage oocytes (By similarity). {ECO:0000250}.
Isoform 2: Cell projection, cilium, flagellum. Note=Expressed in the midpiece region of the sperm flagellum.

Subcellular locations from

COMPARTMENTS
Extracellular space Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi Apparatus Nucleus Mitochondrion 0 1 2 3 4 5 Confidence
COMPARTMENTS Subcellular localization image for PRKACA gene
Compartment Confidence
plasma membrane 5
extracellular 5
cytoskeleton 5
nucleus 5
cytosol 5
mitochondrion 4
endoplasmic reticulum 1

Gene Ontology (GO) - Cellular Components for PRKACA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0001669 acrosomal vesicle ISS --
GO:0005634 nucleus IEA,IDA 21630459
GO:0005654 nucleoplasm TAS --
GO:0005737 cytoplasm IEA --
GO:0005739 mitochondrion IEA --
genes like me logo Genes that share ontologies with PRKACA: view

Pathways & Interactions for PRKACA Gene

SuperPathways for PRKACA Gene

SuperPathway Contained pathways
1 DAG and IP3 signaling
2 RET signaling
3 Regulation of PLK1 Activity at G2/M Transition
4 Circadian entrainment
5 G-Beta Gamma Signaling
genes like me logo Genes that share pathways with PRKACA: view

Pathways by source for PRKACA Gene

Gene Ontology (GO) - Biological Process for PRKACA Gene

GO ID Qualified GO term Evidence PubMed IDs
GO:0000086 G2/M transition of mitotic cell cycle TAS --
GO:0001707 mesoderm formation IEA --
GO:0001843 neural tube closure IEA --
GO:0002027 regulation of heart rate TAS 23507255
GO:0002223 stimulatory C-type lectin receptor signaling pathway TAS --
genes like me logo Genes that share ontologies with PRKACA: view

Drugs & Compounds for PRKACA Gene

(61) Drugs for PRKACA Gene - From: DrugBank, ApexBio, DGIdb, HMDB, Tocris, and Novoseek

Name Status Disease Links Group Role Mechanism of Action Clinical Trials
Adenosine triphosphate Approved Nutra 0
Pentanal Experimental Pharma Target 0
cyclic amp Experimental Pharma 0
(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE Experimental Pharma Target 0
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE Experimental Pharma Target 0

(3) Additional Compounds for PRKACA Gene - From: Novoseek, Tocris, and HMDB

Name Synonyms Role CAS Number PubChem IDs PubMed IDs
ADP
  • Adenosindiphosphorsaeure
  • Adenosine 5'-pyrophosphate
  • Adenosine diphosphate
  • Adenosine pyrophosphate
  • Adenosine-5'-diphosphate
Full agonist, Agonist 58-64-0
H 89 dihydrochloride
130964-39-5

(5) Tocris Compounds for PRKACA Gene

Compound Action Cas Number
cAMPS-Sp, triethylammonium salt Cell-permeable cAMP analog 93602-66-5
H 89 dihydrochloride Protein kinase A inhibitor 130964-39-5
KT 5720 Selective protein kinase A inhibitor 108068-98-0
PKA inhibitor fragment (6-22) amide Potent protein kinase A inhibitor 121932-06-7
PKI 14-22 amide, myristoylated Cell-permeable protein kinase A inhibitor 201422-03-9

(9) ApexBio Compounds for PRKACA Gene

Compound Action Cas Number
A-674563 Akt1/PKA/CDK2 inhibitor,potent and selective 552325-73-2
AT7867 Akt1/2/3 and p70S6K/PKA inhibitor 857531-00-1
cGMP Dependent Kinase Inhibitor Peptide 82801-73-8
Daphnetin Protein kinases inhibitor for EGFR/PKA/PKC 486-35-1
GF 109203X Protein kinase C,MLCK,PKG and PKA inhibitor 133052-90-1
H 89 2HCl Potent PKA inhibitor 130964-39-5
K-252c Protein kinase inhibitor 85753-43-1
PKA inhibitor fragment (6-22) amide 121932-06-7
PKI 14-22 amide, myristoylated PKA inhibitor 201422-03-9
genes like me logo Genes that share compounds with PRKACA: view

Transcripts for PRKACA Gene

Unigene Clusters for PRKACA Gene

Protein kinase, cAMP-dependent, catalytic, alpha:
Representative Sequences:

Inhibitory RNA Products

Clone Products

Flow Cytometry Products

Alternative Splicing Database (ASD) splice patterns (SP) for PRKACA Gene

ExUns: 1 ^ 2 ^ 3 ^ 4 ^ 5 ^ 6 ^ 7a · 7b ^ 8a · 8b ^ 9 ^ 10a · 10b ^ 11 ^ 12
SP1: - -
SP2: - - - -
SP3: -
SP4: - -
SP5:

Relevant External Links for PRKACA Gene

GeneLoc Exon Structure for
PRKACA
ECgene alternative splicing isoforms for
PRKACA

Expression for PRKACA Gene

mRNA expression in normal human tissues from GTEx, Illumina, BioGPS, and SAGE for PRKACA Gene

Integrated Proteomics: protein expression in normal tissues and cell lines from ProteomicsDB, PaxDb, MaxQB, and MOPED for PRKACA Gene



Protein tissue co-expression partners for PRKACA Gene

NURSA nuclear receptor signaling pathways regulating expression of PRKACA Gene:

PRKACA

SOURCE GeneReport for Unigene cluster for PRKACA Gene:

Hs.631630

mRNA Expression by UniProt/SwissProt for PRKACA Gene:

P17612-KAPCA_HUMAN
Tissue specificity: Isoform 1 is ubiquitous. Isoform 2 is sperm-specific and is enriched in pachytene spermatocytes but is not detected in round spermatids.
genes like me logo Genes that share expression patterns with PRKACA: view

No data available for mRNA expression in embryonic tissues and stem cells from LifeMap Discovery , mRNA differential expression in normal tissues and Protein differential expression in normal tissues for PRKACA Gene

Orthologs for PRKACA Gene

This gene was present in the common ancestor of animals and fungi.

Orthologs for PRKACA Gene

Organism Taxonomy Gene Similarity Type Details
chimpanzee
(Pan troglodytes)
Mammalia PRKACA 34 35
  • 99.8 (n)
cow
(Bos Taurus)
Mammalia PRKACA 34 35
  • 93.16 (n)
dog
(Canis familiaris)
Mammalia PRKACA 34 35
  • 92.76 (n)
mouse
(Mus musculus)
Mammalia Prkaca 34 16 35
  • 91.26 (n)
oppossum
(Monodelphis domestica)
Mammalia -- 35
  • 91 (a)
OneToMany
rat
(Rattus norvegicus)
Mammalia Prkaca 34
  • 90.98 (n)
platypus
(Ornithorhynchus anatinus)
Mammalia -- 35
  • 88 (a)
OneToMany
chicken
(Gallus gallus)
Aves -- 35
  • 30 (a)
ManyToMany
lizard
(Anolis carolinensis)
Reptilia -- 35
  • 74 (a)
OneToMany
tropical clawed frog
(Silurana tropicalis)
Amphibia prkaca 34
  • 77.97 (n)
zebrafish
(Danio rerio)
Actinopterygii prkacaa 35
  • 94 (a)
ManyToMany
prkacab 34 35
  • 78.44 (n)
CABZ01071153.1 35
  • 10 (a)
ManyToMany
rainbow trout
(Oncorhynchus mykiss)
Actinopterygii Omy.1053 34
fruit fly
(Drosophila melanogaster)
Insecta Pka-C1 36
  • 82 (a)
Pka-C3 36
  • 56 (a)
CG12069 36
  • 50 (a)
Pka-C2 36 35
  • 48 (a)
worm
(Caenorhabditis elegans)
Secernentea F47F2.1a 36
  • 52 (a)
F47F2.1b 36
  • 51 (a)
kin-1 35
  • 46 (a)
OneToMany
A. gosspyii yeast
(Ashbya gossypii)
Saccharomycetes AGOS_AFL090W 34
  • 55.8 (n)
baker's yeast
(Saccharomyces cerevisiae)
Saccharomycetes TPK2 34 35
  • 53.38 (n)
TPK1 35 37
  • 41 (a)
ManyToMany
TPK3 35
  • 39 (a)
ManyToMany
K. lactis yeast
(Kluyveromyces lactis)
Saccharomycetes KLLA0D03190g 34
  • 51.59 (n)
fission yeast
(Schizosaccharomyces pombe)
Schizosaccharomycetes pka1 34
  • 52.31 (n)
sea squirt
(Ciona savignyi)
Ascidiacea -- 35
  • 22 (a)
ManyToMany
Species where no ortholog for PRKACA was found in the sources mined by GeneCards:
  • Actinobacteria (Mycobacterium tuberculosis)
  • African clawed frog (Xenopus laevis)
  • African malaria mosquito (Anopheles gambiae)
  • Alicante grape (Vitis vinifera)
  • alpha proteobacteria (Wolbachia pipientis)
  • amoeba (Dictyostelium discoideum)
  • Archea (Pyrococcus horikoshii)
  • barley (Hordeum vulgare)
  • beta proteobacteria (Neisseria meningitidis)
  • bread mold (Neurospora crassa)
  • Chromalveolata (Phytophthora infestans)
  • common water flea (Daphnia pulex)
  • corn (Zea mays)
  • E. coli (Escherichia coli)
  • filamentous fungi (Aspergillus nidulans)
  • Firmicute bacteria (Streptococcus pneumoniae)
  • green algae (Chlamydomonas reinhardtii)
  • honey bee (Apis mellifera)
  • loblloly pine (Pinus taeda)
  • malaria parasite (Plasmodium falciparum)
  • medicago trunc (Medicago Truncatula)
  • moss (Physcomitrella patens)
  • orangutan (Pongo pygmaeus)
  • pig (Sus scrofa)
  • rice (Oryza sativa)
  • rice blast fungus (Magnaporthe grisea)
  • schistosome parasite (Schistosoma mansoni)
  • sea anemone (Nematostella vectensis)
  • sea urchin (Strongylocentrotus purpuratus)
  • sorghum (Sorghum bicolor)
  • soybean (Glycine max)
  • stem rust fungus (Puccinia graminis)
  • sugarcane (Saccharum officinarum)
  • thale cress (Arabidopsis thaliana)
  • tomato (Lycopersicon esculentum)
  • toxoplasmosis (Toxoplasma gondii)
  • Trichoplax (Trichoplax adhaerens)
  • wheat (Triticum aestivum)

Evolution for PRKACA Gene

ENSEMBL:
Gene Tree for PRKACA (if available)
TreeFam:
Gene Tree for PRKACA (if available)

Paralogs for PRKACA Gene

Paralogs for PRKACA Gene

genes like me logo Genes that share paralogs with PRKACA: view

Variants for PRKACA Gene

Sequence variations from dbSNP and Humsavar for PRKACA Gene

SNP ID Clin Chr 19 pos Sequence Context AA Info Type
rs386352352 Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830], Pathogenic 14,097,604(-) GTACC(G/T)GGCCC reference, missense
rs724160013 Pathogenic 14,097,621(-) CCTTG(-/GTG)GCGGC cds-indel
rs10413873 -- 14,099,608(+) ttttg(G/T)atttt intron-variant
rs10414133 -- 14,099,755(+) TTCTG(G/T)ATATA intron-variant
rs10418503 -- 14,096,959(+) CTAAG(C/T)GAGGG intron-variant

Structural Variations from Database of Genomic Variants (DGV) for PRKACA Gene

Variant ID Type Subtype PubMed ID
nsv953980 CNV deletion 24416366
nsv833761 CNV loss 17160897
nsv828455 CNV gain 20364138
nsv828454 CNV gain 20364138
nsv828452 CNV loss 20364138
nsv578663 CNV loss 21841781
nsv578661 CNV loss 21841781
nsv578658 CNV loss 21841781
nsv578645 CNV loss 21841781
nsv578642 CNV gain 21841781
nsv1143911 CNV deletion 24896259
nsv1071913 CNV deletion 25765185
esv2677290 CNV deletion 23128226
esv22154 CNV gain 19812545
dgv6279n54 CNV loss 21841781
dgv6276n54 CNV gain 21841781
dgv6274n54 CNV loss 21841781
dgv49n68 CNV loss 17160897

Variation tolerance for PRKACA Gene

Residual Variation Intolerance Score: 17% of all genes are more intolerant (likely to be disease-causing)
Gene Damage Index Score: 0.24; 5.47% of all genes are more intolerant (likely to be disease-causing)

Relevant External Links for PRKACA Gene

Human Gene Mutation Database (HGMD)
PRKACA
SNPedia medical, phenotypic, and genealogical associations of SNPs for
PRKACA

No data available for Polymorphic Variants from UniProtKB/Swiss-Prot for PRKACA Gene

Disorders for PRKACA Gene

MalaCards: The human disease database

(5) MalaCards diseases for PRKACA Gene - From: OMIM, ClinVar, Orphanet, Swiss-Prot, and GeneCards

Disorder Aliases PubMed IDs
pigmented nodular adrenocortical disease, primary, 4
  • cushing syndrome, acth-independent adrenal, somatic
hepatocellular fibrolamellar carcinoma
  • fibrolamellar hepatocellular carcinoma
primary pigmented nodular adrenocortical disease
  • ppnad
cushing's syndrome
  • cushing syndrome
osteoporosis
  • osteoporosis, postmenopausal, susceptibility
- elite association - COSMIC cancer census association via MalaCards

UniProtKB/Swiss-Prot

KAPCA_HUMAN
  • Primary pigmented nodular adrenocortical disease 4 (PPNAD4) [MIM:615830]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Adrenal glands show overall normal size and weight, and multiple small yellow-to-dark brown nodules surrounded by a cortex with a uniform appearance. Microscopically, there are moderate diffuse cortical hyperplasia with mostly nonpigmented nodules, multiple capsular deficits and massive circumscribed and infiltrating extra-adrenal cortical excrescences with micronodules. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. {ECO:0000269 PubMed:24571724, ECO:0000269 PubMed:24700472, ECO:0000269 PubMed:24747643, ECO:0000269 PubMed:24855271}. Note=The disease is caused by mutations affecting the gene represented in this entry.

Relevant External Links for PRKACA

Genetic Association Database (GAD)
PRKACA
Human Genome Epidemiology (HuGE) Navigator
PRKACA
Atlas of Genetics and Cytogenetics in Oncology and Haematology:
PRKACA
genes like me logo Genes that share disorders with PRKACA: view

No data available for Genatlas for PRKACA Gene

Publications for PRKACA Gene

  1. DNA binding of repressor nuclear factor-kappaB p50/p50 depends on phosphorylation of Ser337 by the protein kinase A catalytic subunit. (PMID: 15642694) Guan H. … Ricciardi R.P. (J. Biol. Chem. 2005) 3 4 22 64
  2. Recurrent somatic mutations underlie corticotropin-independent Cushing's syndrome. (PMID: 24855271) Sato Y. … Ogawa S. (Science 2014) 3 4 64
  3. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. (PMID: 24571724) Beuschlein F. … Allolio B. (N. Engl. J. Med. 2014) 3 4 64
  4. Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome. (PMID: 24700472) Cao Y. … Ning G. (Science 2014) 3 4 64
  5. Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. (PMID: 24747643) Goh G. … Lifton R.P. (Nat. Genet. 2014) 3 4 64

Products for PRKACA Gene

Sources for PRKACA Gene

Content
Loading form....